Nanocs' amino acid and peptide PEG conjugates were made from the covalent attachment of PEG to various amino acid derivatives. Conjugates were provided in lyophilized powder form.
Especificações
Especificações e pureza
MW 5000 Da
Condições de armazenamento de armazenamento
Room temperature
Enviado em
Normal
Dados avançados
Certificados(CoA,COO,BSE/TSE e Mapa de Análise)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Find and download the COA for your product by matching the lot number on the packaging.
Lyophilized powder form;Soluble in regular aqeous solution and common organic solvents;
Calculadoras de soluções
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
Revisões
Avaliações dos Clientes
Application Protocols
Not applicable to this product. No validated immunoassay protocols (WB, IHC, IF, FC) or diagnostic procedures are associated with this reagent. For general coupling/formulation workflows, see the Reaction Conditions and Synthetic Utility tabs for guidance.
Biological Roles
This product is intended for research use only. No biological activity is claimed for the material itself. The following information is general background relevant to components of the conjugate.
Aspartic acid (literature/general):
A proteinogenic, acidic amino acid participating in enzyme active sites, salt bridges, and metal coordination in proteins.
Precursor/intermediate in metabolic pathways (e.g., urea cycle, nucleotide biosynthesis). pKa values of the α‑ and β‑carboxyls (~2.0 and ~3.9) give it a net negative charge at physiological pH.
Generally considered biologically inert and highly water‑solvated; reduces nonspecific protein adsorption and aggregation in vitro.
Used as a hydrophilic spacer in bioconjugation studies to modulate spacing and reduce steric hindrance.
Conjugate‑level considerations (general):
PEGylation of amino acids introduces a hydrophilic, flexible tether that can influence solubility, diffusion, and surface interactions of the final constructs in biochemical assays.
The number and accessibility of remaining carboxyl groups on the Asp residue determine the ionic character and coupling capacity toward amines under controlled pH conditions.
Caveat: Exact ionization behavior, binding, and any emergent properties depend on the detailed structure (linkage type, MW, and degree of ionization), which are not specified for this item; consult the CoA and characterize within your assay context.
Buffer Applications
Buffer use is not a typical primary application for mPEG–Aspartic Acid. While free aspartic acid can participate in buffering near pH 2–4 (literature pKa ~2.0 and ~3.9), PEGylation and conversion of one or more carboxyls to amide/ester linkages alter ionization and substantially diminish classical buffering capacity.
Practical guidance:
Do not rely on mPEG–Asp as a buffer component. Instead, select standard buffers (e.g., MES pH 5.5–6.5 for carbodiimide chemistry; phosphate or HEPES near neutral for storage/formulations) and use mPEG–Asp as a solute or reactive component within that buffer.
If ionic strength adjustments are needed for solubility or coupling, use inert salts (e.g., NaCl) rather than attempting to leverage the conjugate’s acid groups.
If you must estimate acid content (for titration or charge balancing), determine the titratable acidity (meq/g) experimentally for the specific lot; do not assume free aspartate pKa values apply after PEGylation.
For routine bioconjugation, see the Reaction Conditions tab for buffer choices and pH control.
Green Alternatives
Context: PEGylated reagents are widely used due to benign handling and aqueous compatibility. When evaluating greener options, consider life‑cycle, solvent use, and biodegradability.
Polyglycerol (hyperbranched): renewable feedstocks, high hydrophilicity; different rheology and functionalization chemistry versus PEG.
Polysarcosine: non‑ionic, peptide‑mimetic backbone; good aqueous stability; synthesis can be solvent‑intensive.
Poly(2‑oxazoline)s: tunable hydrophilicity; may offer improved thermal stability; monomer synthesis often requires aprotic polar solvents.
Within PEG chemistry, greener process choices:
Prefer water or water‑miscible green co‑solvents (ethanol, 2‑MeTHF for extractions) over chlorinated solvents during activation/purification.
Use water‑soluble carbodiimides (EDC) to avoid insoluble urea byproducts (DCC), simplifying aqueous workup.
Employ enzymatic ligations (e.g., microbial transglutaminase for glutamyl coupling) when substrate scope permits, reducing hazardous reagents.
Trade‑offs:
Alternative polymers may alter biophysical performance (protein resistance, viscosity, critical solution temperature) and coupling orthogonality; re‑optimization is typically required.
PEG has extensive safety/compatibility data in research contexts; greener substitutes may lack equivalent characterization for some applications.
Practical recommendation: If retaining PEG, select activation routes compatible with water/ethanol, minimize protecting group steps, and recover solvents. If switching polymers, verify functional group density and MW distribution to match performance targets.
Pharmaceutical Uses
For research use only. No medical or clinical claims are made. The following describes formulation‑oriented roles observed in the research and development literature for related materials; suitability of this specific item must be established experimentally.
Excipient/function roles (literature/general):
Hydrophilic spacer or surface modifier in prototype delivery systems to reduce nonspecific adsorption and improve colloidal stability (in vitro).
Component in model polymer–drug conjugates or hydrogel networks where the aspartyl carboxyl groups provide sites for amide formation with amines.
Solubilization aid in research formulations, leveraging PEG’s water affinity to enhance apparent solubility of conjugated moieties.
Material selection considerations:
Average MW and PDI of the PEG segment dictate rheology, diffusivity, and clearance in model systems; end‑group fidelity and remaining carboxyl loading govern coupling efficiency.
Residual solvent/moisture and counterion content can affect stability and assay outcomes; verify via CoA/Spec Sheet.
Regulatory compendia: No pharmacopeial designation or grade is provided for this item. If compendial compliance is required in your workflow (e.g., PEG NF/Ph. Eur.), confirm specifications or source appropriate materials.
Process notes:
For sterile research applications, prepare solutions in sterile buffers and 0.22 µm filter; confirm endotoxin/bioburden if critical to your study. Documentation is not specified for this SKU and must be verified per lot.
Physical Properties
Item-specific physicochemical values are not provided in the Product Data for this polymeric reagent; consult the CoA/Spec Sheet for the batch’s average molecular weight, polydispersity index (PDI), and residual solvent/moisture content if applicable.
Appearance: Not specified for this item; refer to CoA/Spec Sheet. (General note: mPEG reagents are often white to off‑white solids or waxy flakes; appearance varies with MW.)
Molecular weight (item-specific): Not specified for this item; refer to CoA/Spec Sheet.
Solubility (literature/general):
High solubility in water across a broad MW range; solubility may decrease with increasing PEG chain length.
Miscible or soluble in many polar organics (methanol, ethanol, isopropanol, acetone, acetonitrile, DMF, DMSO). Limited solubility in nonpolar solvents (hexanes, toluene) unless ion-pairing or co‑solvents are used.
pKa (literature/general): Aspartic acid has pKa1 ~2.0 (α‑COOH) and pKa2 ~3.9 (β‑COOH) in the free amino acid; PEGylation and amide/ester formation shift these values and typically reduce the number of ionizable groups available.
Melting behavior (literature/general): mPEGs show MW‑dependent softening/melting (approx. 45–65 °C for mid‑MW ranges); conjugation and salt form can broaden or shift transitions.
Density and refractive index: Not specified for this item; refer to CoA/Spec Sheet.
Note: As a polymer, properties are averages that depend on the PEG chain length (n), end‑group chemistry, and salt state of the aspartate. Verify lot‑specific data on the CoA.
Quality and Grades
Item-specific grade/purity: Not specified for this item; refer to CoA/Spec Sheet.
Interpreting grade for PEGylated reagents (general guidance):
Polymer quality is defined by average molecular weight (Mn/Mw), polydispersity index (PDI), end‑group fidelity (functionalization efficiency), and low residuals (water, solvents, catalysts, salts). For bio‑oriented research, additional controls may include bioburden/endotoxin and trace metal limits.
“Analytical” or “reagent” grades emphasize low inorganic/organic impurities. “Polymer synthesis” or “bioconjugation” grades prioritize narrow PDI and verified end‑group functionality. “HPLC grade” is not typically applicable to solid polymers but may describe solvents used in purification.
Stabilizers: None specified for this item. If present in a specific lot, stabilizers or counterions will be listed on the CoA; these can influence solubility, pH response, and coupling efficiency.
What to verify on receipt (best practice):
Lot‑specific Mn/Mw and PDI; titratable acid content (meq/g) if carboxyl groups are available.
Residual solvent and moisture (Karl Fischer) when coupling sensitivity is critical.
End‑group identity and loading via NMR (1H/13C), FTIR (C=O bands), and titration; SEC (GPC) for PDI.
Documentation: Request CoA/SDS for each lot to confirm specifications align with your application (e.g., bioconjugation versus materials synthesis).
Reaction and Applications
Applications are polymer/materials and bioconjugation oriented; specific use cases depend on the available carboxyl functionality and linkage type to PEG.
Carbodiimide‑mediated amide formation (EDC/HOBt or EDC/NHS) to couple the aspartyl carboxyl group(s) to amines (peptides, proteins, surfaces) under mildly acidic buffers (MES, pH ~5–6) or in DMF/DMSO with tertiary amines.
Active ester strategies (DCC/NHS or DIC/NHS) to pre‑form mPEG‑Asp‑NHS esters for subsequent coupling in aqueous or mixed media.
Uronium/Phosphonium coupling agents (HATU/HBTU/TBTU) in DMF/NMP with DIPEA for rapid amide bond formation to sterically hindered amines.
Protection/deprotection of the α‑amino or side‑chain carboxyl if selectivity is needed (e.g., Boc protection on amine; OtBu/OBn esters on carboxyls).
Research uses (non‑clinical):
As a hydrophilic spacer to modify surfaces, nanoparticles, and polymers to reduce nonspecific adsorption in biomaterials research.
As a building block to access poly(aspartate) derivatives, PEG‑grafted polypeptidomimetics, and degradable linkers via ester/amide chemistry.
Precursor for multifunctional PEGs: activation of one carboxyl to NHS while retaining another functionality for orthogonal ligations.
Practical tips:
Quantify available –COOH loading (meq/g) for stoichiometric accuracy; PDI affects functional group equivalence.
Maintain low temperatures and controlled pH during activation to minimize O→N acyl migration and hydrolysis.
Remove urea byproducts (DCC) by cold precipitation into ether or via dialysis/SEC depending on MW.
Reaction Conditions
General, literature‑based guidance for coupling and derivatization of mPEG–Asp (optimize per substrate and lot characteristics):
EDC/NHS aqueous coupling to primary amines:
Solvent: MES buffer (50–100 mM), pH 5.0–6.0; optional 5–30% DMF or DMSO to aid dissolution.
Reagents: 1.0–1.5 equiv EDC per –COOH; 1.0–2.0 equiv NHS (or sulfo‑NHS in fully aqueous media).
Temperature/time: 0–25 °C, 0.5–2 h for activation; add amine (pH adjusted to 7.2–7.8) and react 1–4 h.
Notes: Control pH carefully; excess base accelerates hydrolysis of O‑acylisourea/NHS ester. Remove byproducts by dialysis (MWCO chosen > factor of 3–5 below PEG MW), SEC, or precipitation.
Temperature/time: 0 °C to rt, 2–12 h; filter off dicyclohexylurea; proceed to coupling or isolate NHS ester.
Uronium reagents (HATU/HBTU) for difficult amines:
Solvent: DMF/NMP; base: DIPEA (2–4 equiv relative to –COOH).
Temperature/time: rt, 0.5–2 h.
Purification and workup tips:
Precipitation into cold diethyl ether or acetone can remove small‑molecule reagents for mid‑ to high‑MW PEGs.
Dialysis against water or buffered saline; or ultrafiltration (e.g., 10–30 kDa MWCO as appropriate). SEC can give finer separation of PDI shifts.
Expected outcomes:
Yields are commonly reported as mass recovery for polymers; coupling efficiencies are better gauged by titration or NMR end‑group analysis rather than percent yield.
Safety and Handling
Safety profile for this specific SKU is not provided in the Product Data; always consult the SDS for authoritative guidance.
GHS information (item-specific):
Signal word: Not specified for this item; refer to SDS.
Hazard statements, pictograms, and classification: Not specified for this item; refer to SDS.
General handling (polyethylene glycol–based reagents with amino acid functionality; literature/general):
Typically considered of low acute toxicity and low volatility; avoid dust formation and inhalation of particulates.
Prevent contact with eyes/skin by using standard PPE: lab coat, safety glasses, and appropriate gloves (e.g., nitrile). Handle powders in a fume hood or ventilated enclosure to control aerosols.
Hygroscopic tendency is common for PEG conjugates; keep containers tightly closed and minimize exposure to ambient moisture.
Incompatibilities and reactivity (general):
Avoid strong oxidizers and strong acids/bases that can hydrolyze ester linkages or degrade PEG at elevated temperature.
Thermal decomposition may evolve irritating fumes (e.g., CO/CO2/organics). Do not heat above necessary processing temperatures.
First‑aid overview (general, non‑exhaustive; defer to SDS):
Inhalation: move to fresh air; seek medical advice if symptoms persist.
Skin/eye contact: rinse with water for several minutes; remove contaminated clothing; obtain medical attention if irritation develops.
Ingestion: rinse mouth; do not induce vomiting; seek medical attention.
Waste: Dispose according to institutional and local regulations for non‑halogenated organic solids/polymers.
Solvent Selection
Choosing solvents for mPEG–Asp depends on MW, salt state, and the planned transformation (coupling, activation, formulation).
Polarity class and miscibility (literature/general):
Highly hydrophilic polyether with carboxylic functionality; readily disperses in water and polar protic solvents (MeOH, EtOH, i‑PrOH). Good solubility in polar aprotics (DMF, DMSO, NMP, acetonitrile). Limited solubility in non‑polars (toluene, hexanes).
Ionization of carboxyls (pH > pKa) increases aqueous solubility; conversion to esters/amide coupling intermediates may favor aprotic solvents.
Typical choices by task:
Carbodiimide couplings (EDC/NHS): water or mixed aqueous buffers (MES, pH 5.0–6.5) with co‑solvents (DMF/DMSO) to ensure homogeneity.
Active ester chemistry (DCC/NHS): anhydrous DMF, DCM/DMF mixtures, or DMSO; avoid high water content to limit hydrolysis.
Salt exchange/neutralization: water, minimal alcohol, then lyophilize.
Degas solutions for moisture‑sensitive activations; PEG binds water strongly.
Viscosity rises with concentration/MW; use gentle heating (≤40–45 °C) to assist dissolution, avoiding prolonged heating.
Filtration through 0.22 µm PTFE or PES is generally compatible; avoid cellulose acetate with strong DMF/NMP systems.
Alternatives comparison (general): For less hydrophilic analogs consider PEG–alkyl copolymers; for fully aqueous systems, maintain pH near 5–6 during EDC/NHS activation to balance reactivity and stability.
Storage and Reconstitution
Storage conditions (item-specific from Product Data):
Store at room temperature. Keep container tightly closed in a dry, well‑ventilated place. Protect from moisture.
Shipped: Normal conditions (ambient).
Stability notes (general for PEG conjugates):
Hygroscopic; prolonged exposure to air may increase water content and affect accurate weighing and coupling efficiency.
Avoid extended heating; ester linkages (if present) are susceptible to hydrolysis under strong acid/base or elevated temperature.
Reconstitution (general guidance):
Water: Add gradually with gentle stirring; slight warming (≤40–45 °C) can accelerate dissolution. Adjust pH to maintain desired ionization state (pH 5–7 for activation steps; neutral for storage).
Polar organics: DMSO or DMF yield clear solutions at moderate concentrations; for mixed aqueous systems, add organic solvent first to wet the polymer, then buffer.
Filtration: Clarify through a 0.22 µm PES or PTFE filter if sterile solutions are required for research; avoid filters incompatible with chosen solvent.
Aliquoting and storage of solutions:
Prepare single‑use aliquots to minimize repeated exposure to air/water. Store aqueous solutions at 2–8 °C for short term; for longer term, freeze and avoid repeated freeze–thaw cycles.
Documentation: For lot‑specific details (e.g., counterion, residual solvent, titratable acidity), consult the CoA/Spec Sheet.
Research Use Note: For research use only.
Structure and Identity
Brief overview: “mPEG Aspartic Acid” denotes a methoxy‑poly(ethylene glycol) (mPEG) chain covalently attached to L‑aspartic acid, yielding a PEGylated amino acid scaffold with carboxyl functionality available for further derivatization. Exact structural details are item‑specific for polymers.
Item-specific identifiers:
CAS: Not specified for this item; refer to CoA/Spec Sheet.
InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
SMILES: Not specified for this item; refer to CoA/Spec Sheet.
Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
Structural features (general/literature description):
Contains a linear, poly(ethylene oxide) backbone terminated with a methoxy group at one end (–O–(CH2CH2O)n–CH3) and tethered to an aspartic acid residue.
Aspartic acid contributes an α‑amino (–NH2/–NH– in amide linkages) and a β‑carboxylate side chain; depending on the synthetic route, one or both carboxyl groups may remain free (–COOH/–COO−) for further coupling. Common constructs include mPEG–amide–Asp(–COOH) or mPEG–ester–Asp(–COOH).
Stereochemistry: Aspartic acid is typically the L‑enantiomer in research reagents; polymer attachment does not create new stereogenic centers on PEG. If chirality matters, verify on the CoA.
Functional group inventory: polyether (PEG), carboxylic acid(s), and potentially an amide or ester linkage at the PEG–Asp junction.
2D structure in words (general): a long, flexible ether chain (PEG) capped by a methyl at one terminus; the opposite terminus is joined to an aspartyl moiety featuring a two‑carbon side chain terminating in a carboxyl group, plus the α‑carboxyl/α‑amino functionality governed by the coupling scheme.
Synthetic Utility
From a synthetic perspective, mPEG–Asp serves as a bifunctional scaffold combining a nonionic, water‑solvated polymer chain with acidic functionality for bond formation.
Functional group reactivity (literature/general):
Carboxyl group(s) on the Asp residue: amenable to activation to mixed anhydrides, acid chlorides (with care), active esters (NHS, PFP), or direct EDC/urea coupling to amines.
Potential α‑amino functionality (depending on the construct): can be protected (Boc, Fmoc) and later deprotected for orthogonal ligation.
PEG hydroxyl terminus is capped as methoxy; nonreactive under most conditions, providing a monofunctional PEG tail to impose hydrophilicity.
Retrosynthetic value:
Enables installation of a single PEG chain onto targets bearing amines through amide bond formation while preserving or consuming selected Asp carboxyls for fine‑tuned architectures (e.g., spacers, branching points, degradable esters).
Typical transformations:
Synthesis of PEGylated amides/esters on small molecules, peptides, and surfaces.
Formation of cross‑linked networks via diamine/diacid strategies if both Asp carboxyls are available and differentially protected.
Preparation of heterobifunctional PEG constructs (e.g., mPEG–Asp–NHS, mPEG–Asp–Azide) using orthogonal activation to interface with click chemistry or thiol–maleimide couplings downstream.
Analytical control:
SEC/GPC for Mw/PDI; NMR to verify end‑group loading and coupling; FTIR for C=O/amide bands; titration for acid equivalents; MALDI or ESI (if MW in range) for distribution assessment.
Target Specificity
Not applicable to this product. This is a PEGylated small‑molecule/polymer reagent, not an antibody or affinity ligand. No antigen/epitope/clone/isotype information is associated with this SKU.
Perguntas frequentes
How should this product be stored?
Store at room temperature.
How is this product shipped?
This product ships under standard ambient conditions. No temperature-controlled packaging is required.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.
Usamos cookies para garantir o funcionamento adequado do site e, quando permitido, para melhorar a sua experiência. Você pode gerenciar suas preferências a qualquer momento nas Configurações. Saiba mais em nossa Política de Cookies.
Deseja que lhe enviemos uma mensagem quando tivermos descontos disponíveis?
Lembrar-me mais tarde
Obrigado! Por favor, verifique a sua caixa de entrada de e-mail para confirmar.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.